Synthesis of 3,7-di-O-benzyl-kaempferol-4'-O-(2'', 3'', 4''-tri-O-acetyl)--D-glucuronic acid methyl ester (3c).
Scheme S2 Modified Koenigs-Knorr glucuronidation of 3b.
3,7-di-O-benzyl-kaempferol (3b, 200.0 mg, 429.2 µmol), calcium sulfate (470.0 mg), and silver-(I)oxide (248.6 mg, 1.07 mmol, 2.5 eq) were suspended in 5.6 mL acetonitrile at 0°C. Afterwards, 1-bromo-2,3,4-tri-O-acetyl-α-D-glucuronic acid methyl ester (210.0 mg, 536.5 µmol, 1.25 eq) and 925 µL pyridine were added. After 15 min, the ice bath was removed. The reaction mixture was stirred at room temperature for 3.5 h and then filtered. The crude product was purified within two steps by flash column chromatography followed by semipreparative HPLC with an H 2 O/acetonitrile gradient and yielded 3c as a pale yellow solid (77 mg, 18%).
Synthesis of kaempferol-4'-O-(2'', 3'', 4''-tri-O-acetyl)-β-D-glucuronic acid methyl ester (3d).
Scheme S3 Transfer hydrogenation of benzyl ether protecting groups. 3c (53.6 mg, 68.5 µmol) was suspended in 8 mL EtOH and 2 mL cyclohexene (CyHe). Afterwards, Pd(OH) 2 on charcoal (12.0 mg) was added. The mixture was stirred under an N 2 atmosphere and refluxed for 45 min. After cooling, the suspension was filtrated and the solvent was evaporated under a nitrogen stream.
The product 3d (pale yellow solid, 36.4 mg, 88%) was used without any further purification in the next step.
Deprotection 4 Scheme S4 Deprotection under alkaline conditions to yield 3. 3d (36.4 mg, 60.4 µmol) was dissolved in 20 mL 50% aq. MeOH. After the addition of 0.6 mL aq. sodium carbonate (0.5 M), the reaction mixture was stirred at room temperature for 90 min. After cooling, the pH was adjusted to ≤ 3 with Dowex 50 W X 4 resin. The mixture was filtrated and the residue was washed with 20 mL 50% aq.
MeOH and 20 mL MeOH. The crude product was purified by semipreparative HPLC with an H 2 O + 0.1% TFA/acetonitrile + 0.1% TFA gradient and yielded 3 as a yellow solid (10.5 mg, 38%). UV/Vis (MeCN): λ max (ε) = 250, 267, 318, 363 (10333) 
Synthesis of kaempferol-7-O-β-D-glucuronide (4)
Synthesis of 3,5,7,4'-tetra-O-acetyl-kaempferol (4a).
Scheme S5 Peracetylation of 3a.
3a (500 mg, 1.75 mmol) was dissolved in 4.95 mL acetic anhydride. After addition of 524 µL pyridine, the reaction mixture was heated to reflux (145 °C) for 5 h. Ice-cold H 2 O was added (8.7 mL) and the precipitate was filtered off and washed with ice-cold H 2 O. The crude product 4a (white solid, 728 mg, 92%) was used without further purification in the next step.
Synthesis of 3,5-di-O-acetyl-kaempferol (4b). One-pot synthesis of 3, 
Scheme S6
Scheme S9 Modified Koenigs-Knorr glucuronidation of 3a.
3a (75.0 mg, 262 µmol), potassium carbonate (36.0 mg, 262 µmol, 1 eq), and 1-bromo-2,3,4-tri-O-acetyl-α-D-glucuronic acid methyl ester (728.0 mg, 1833 µmol, 7 eq) were suspended under an N 2 atmosphere and 0°C in 2.6 mL DMF. The ice bath was removed and after 72 h another 36.0 mg of potassium carbonate were added.
The reaction mixture was stirred overall for 96 h at room temperature. Subsequently, 50 mL of EtOAc were added to the reaction mixture, which was extracted two times with 50 mL H 2 O each. The organic phase was dried under an N 2 stream before the crude product was purified by semipreparative HPLC with an H 2 O/acetonitrile gradient and yielded 5a as a pale yellow solid (14.9 mg, 9%).
Deprotection 7 Scheme S10 Deprotection under alkaline conditions to yield 5. 5a (7.5 mg, 32.9 µmol) was dissolved in 15 mL 50% aq. MeOH. After the addition of 0.45 mL aq. sodium carbonate (0.5 M), the reaction mixture was stirred at room temperature for 150 min. After cooling, the pH was adjusted to ≤ 3 with Dowex 50 W X 4 resin. The mixture was filtrated and the residue was washed with 20 mL 50 % aq.
MeOH and 20 mL MeOH. 
Synthesis of naringenin-7-O-β-D-glucuronide (11)
Scheme S11 A Naringenin (11a) 
Synthesis of catechol-O-β-D-glucuronide (14)
Scheme S12 A Catechol (14a) eq) was added and the mixture was stirred 4.5 h at 38°C. After filtration, the crude product was purified by flash chromatography on normal phase with an n-hexane/ 
ESIMS:
Mass analyses were carried out on a Thermo Quest Finnigan TSQ 7000, Thermoquest. Mass detection was performed in the negative electrospray ionization mode for 3-5, 11, and 14. Spectra were analyzed with Xcalibur 1.2 software. were carried out in duplicate. Data were subjected to two-way ANOVA followed by Bonferroni posttests using GraphPad Prism 4 software (the levels of significance are *p < 0.05, **p < 0.01, and ***p < 0.001). Dsata were subjected to one-way ANOVA followed by Dunnett's multiple comparison test using GraphPad Prism 4 software (the levels of significance are *p < 0.05, **p < 0.01, and ***p < 0.001). were carried out in duplicate. Data were subjected to two-way ANOVA followed by Bonferroni posttests using GraphPad Prism 4 software (the levels of significance are *p < 0.05, **p < 0.01, and ***p < 0.001). experiments were carried out in duplicate. Data were subjected to two-way ANOVA followed by Bonferroni posttests using GraphPad Prism 4 software (the levels of significance are *p < 0.05, **p < 0.01, and ***p < 0.001). Data in all bar graphs are presented as mean ± SD and at least three independent experiments were carried out in duplicate. Data were subjected to two-way ANOVA followed by Bonferroni posttests using GraphPad Prism 4 software (the levels of significance are *p < 0.05, **p < 0.01, and ***p < 0.001). 
